Asia Pacific Insomnia Market

Asia Pacific Insomnia Market Research Report, By Types Of Therapy (Pharmacological Therapy And Non-Pharmacological Therapy), By Drug Formulation (Capsules, Tablet And Others), By Type Of Diseases (Poor Quality Of Sleep, Sleep Maintenance And Other) - Forecast Till 2035

CAGR
8.12%
2023 Market Size
$ 0.14 Billion
2032 Market Size
$ 0.2 Billion
Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/0176-HCR | Pages: 50 | Author: Rahul Gotadki, Kinjoll Dey
  1. 1 INTRODUCTION
    1. 1.1 DEFINITION
    2. 1.2 SCOPE OF STUDY
      1. 1.2.1 RESEARCH OBJECTIVE
      2. 1.2.2 ASSUMPTIONS & LIMITATIONS
        1. 1.2.2.1 ASSUMPTIONS
        2. 1.2.2.2 LIMITATIONS
    3. 1.3 MARKET STRUCTURE:
  2. 2 RESEARCH METHODOLOGY
    1. 2.1 RESEARCH PROCESS:
    2. 2.2 PRIMARY RESEARCH
    3. 2.3 SECONDARY RESEARCH:
  3. 3 MARKET DYNAMICS
    1. 3.1 DRIVERS
    2. 3.2 RESTRAINTS
    3. 3.3 OPPORTUNITIES
    4. 3.4 MACROECONOMIC INDICATORS
  4. 4 MARKET FACTOR ANALYSIS
    1. 4.1 PORTERS FIVE FORCES MODEL
    2. 4.2 BARGAINING POWER OF SUPPLIERS
    3. 4.3 BARGAINING POWER OF BUYERS
    4. 4.4 THREAT OF NEW ENTRANTS
    5. 4.5 THREAT OF SUBSTITUTES
    6. 4.6 INTENSITY OF RIVALRY
  5. 5 Asia Pacific Insomnia Market, BY TYPES OF THERAPY
    1. 5.1 PHARMACOLOGICAL THERAPY
      1. 5.1.1 BENZODIAZEPINES
      2. 5.1.2 NON-BENZODIAZEPINES
      3. 5.1.3 MELATONIN RECEPTOR AGONISTS
      4. 5.1.4 OTHER
    2. 5.2 NON PHARMACOLOGICAL THERAPY
      1. 5.2.1 RELAXATION THERAPY
      2. 5.2.2 COGNITIVE BEHAVIORAL THERAPY
      3. 5.2.3 SLEEP HYGIENE EDUCATION
      4. 5.2.4 STIMULUS CONTRO
      5. 5.2.5 PARADOXICAL INTENTION
      6. 5.2.6 OTHER
  6. 6 Asia Pacific Insomnia Market, BY DRUG FORMULATION
    1. 6.1 CAPSULES
    2. 6.2 TABLET
    3. 6.3 OTHERS.
  7. 7 Asia Pacific Insomnia Market, BY TYPE OF DISEASE
    1. 7.1 POOR QUALITY OF SLEEP
    2. 7.2 SLEEP MAINTENANCE
    3. 7.3 OTHER.
  8. 8 Asia Pacific Insomnia Market, BY REGION
    1. 8.1 INTRODUCTION
      1. 8.1.1 JAPAN
      2. 8.1.2 CHINA
      3. 8.1.3 INDIA
      4. 8.1.4 AUSTRALIA
      5. 8.1.5 REPUBLIC OF KOREA
      6. 8.1.6 REST OF ASIA-PACIFIC
  9. 9 COMPETITIVE LANDSCAPE
    1. 9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
      1. 9.1.1 STRATEGIC PARTNERSHIP
      2. 9.1.2 MERGER & ACQUISITION
  10. 10 COMPANY PROFILE
    1. 10.1 EISAI, CO.
      1. 10.1.1 OVERVIEW
      2. 10.1.2 PRODUCT OVERVIEW
      3. 10.1.3 FINANCIALS
      4. 10.1.4 KEY DEVELOPMENTS
    2. 10.2 MERCK & CO INC
      1. 10.2.1 OVERVIEW
      2. 10.2.2 PRODUCT OVERVIEW
      3. 10.2.3 FINANCIALS
      4. 10.2.4 KEY DEVELOPMENTS
    3. 10.3 TAKEDA PHARMACEUTICAL COMPANY
      1. 10.3.1 OVERVIEW
      2. 10.3.2 PRODUCT OVERVIEW
      3. 10.3.3 FINANCIALS
      4. 10.3.4 STRATEGY
      5. 10.3.5 KEY DEVELOPMENT
    4. 10.4 SANOFI
      1. 10.4.1 OVERVIEW
      2. 10.4.2 PRODUCT OVERVIEW
      3. 10.4.3 FINANCIALS
      4. 10.4.4 KEY DEVELOPMENTS
    5. 10.5 PFIZER, INC.
      1. 10.5.1 OVERVIEW
      2. 10.5.2 PRODUCT OVERVIEW
      3. 10.5.3 FINANCIALS
      4. 10.5.4 KEY DEVELOPMENTS
    6. 10.6 OTHERS
  11. 11 CONCLUSION
  12. 12 KEY FINDINGS
    1. 12.1 FROM CEO’S VIEWPOINT
      1. 12.1.1 UNMET NEEDS OF THE MARKET
    2. 12.2 KEY COMPANIES TO WATCH
    3. 12.3 PREDICTION OF INSOMNIA CARE INDUSTRY
  13. 13 APPENDIX
Share::
Request Free Sample

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Asia Pacific Insomnia Market by multiple parameters
  • Regional and country-level breakdowns
  • Asia Pacific Insomnia Market by segment
Share::
Request Free Sample
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.